Strong Association Between Weight Reduction and Suppression of Cardiovascular Events in Recent Clinical Trials of DPP4 Inhibitors, GLP-1 Receptor Agonists, and SGLT2 Inhibitors

Detalles Bibliográficos
Autor principal: Yanagawa, Tatsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2018
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135005/
https://www.ncbi.nlm.nih.gov/pubmed/30214654
http://dx.doi.org/10.14740/jocmr3587w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135005/
https://www.ncbi.nlm.nih.gov/pubmed/30214654
http://dx.doi.org/10.14740/jocmr3587w

Ejemplares similares